Takeda's new dengue vaccine, TAK-003, has received prequalification from the World Health Organization (WHO). TAK-003 is the second dengue vaccine to achieve this status. WHO has recommended the ...

Takeda announced Tuesday that it has voluntarily withdrawn its application to the Food and Drug Administration for its dengue vaccine, making it unclear when or if the vaccine will be licensed in ...

"Our vaccine has been approved in 40 countries." New vaccine offers hope in fight against disease that threatens half of ...

Developed by Takeda, it is a live-attenuated vaccine containing weakened versions of the four serotypes of the virus that cause dengue. WHO recommends using TAK-003 in children aged 6–16 in ...

Takeda has unexpectedly withdrawn its marketing application with the FDA for dengue fever vaccine TAK-003 and said it will reconsider whether it will attempt to bring it to market in the US.

The World Health Organization has authorized a second dengue vaccine, aiming to protect millions worldwide against the mosquito-borne disease. The vaccine, named Qdenga, is recommended for ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Takeda (TSE:4502/NYSE:TAK) today announced the company’s dengue vaccine, QDENGA® (Dengue Tetravalent Vaccine ...

American depositary receipts of Takeda Pharmaceutical Co. JP:4502 TAK rose more than 1% in the extended session Tuesday after the Japan-based company said its dengue vaccine got the recommendation ...

Takeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says Much like COVID-19, an epidemic like dengue can be a big problem for governments, not just individuals.

After decades of delays, the first vaccine for dengue fever was introduced seven ... spurring researchers at Japan’s Takeda Pharmaceutical Co. to redouble efforts on an alternative.

July 11 (Reuters) - Takeda Pharmaceutical Co (4502.T), opens new tab said on Tuesday it was voluntarily withdrawing its application for its dengue vaccine candidate, following discussions with the ...

For years, Takeda has been working hard to bring the first travel vaccine for dengue fever to the market. Now, the company can breathe a sigh of relief as the program snagged an approval from the ...